TY - JOUR
T1 - γ-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid β peptides of varying length
AU - Murphy, Michael Paul
AU - Hickman, Lesley Jill
AU - Eckman, Christopher Benjamin
AU - Uljon, Sacha Noelle
AU - Wang, Hong
AU - Golde, Todd Eliot
PY - 1999/4/23
Y1 - 1999/4/23
N2 - γ-Secretase activity is the final cleavage event that releases the amyloid β peptide (Aβ) front the β-secretase cleaved carboxyl-terminal fragment of the amyloid β protein precursor (APP). No protease responsible for this highly unusual, purportedly intramembranous, cleavage has been definitively identified. We examined the substrate specificity of γ- secretase by mutating various residues within or adjacent to the transmembrane domain of the APP and then analyzing Aβ production from cells transfected with these mutant APPs by enzyme-linked immunosorbent assay and mass spectrometry. Aβ production was also analyzed from a subset of transmembrane domain APP mutants that showed dramatic shifts in γ-secretase cleavage in the presence or absence of pepstatin, an inhibitor of γ- secretase activity. These studies demonstrate that γ-secretase's cleavage specificity is primarily determined by location of the γ-secretase cleavage site of APP with respect to the membrane, and that γ-secretase activity is due to the action of multiple proteases exhibiting both a pepstatin-sensitive activity and a pepstatin-insensitive activity. Given that γ-secretase is a major therapeutic target in Alzheimer's disease these studies provide important information with respect to the mechanism of Aβ production that will direct efforts to isolate the γ-secretases and potentially to develop effective therapeutic inhibitors of pathologically relevant γ-secretase activities.
AB - γ-Secretase activity is the final cleavage event that releases the amyloid β peptide (Aβ) front the β-secretase cleaved carboxyl-terminal fragment of the amyloid β protein precursor (APP). No protease responsible for this highly unusual, purportedly intramembranous, cleavage has been definitively identified. We examined the substrate specificity of γ- secretase by mutating various residues within or adjacent to the transmembrane domain of the APP and then analyzing Aβ production from cells transfected with these mutant APPs by enzyme-linked immunosorbent assay and mass spectrometry. Aβ production was also analyzed from a subset of transmembrane domain APP mutants that showed dramatic shifts in γ-secretase cleavage in the presence or absence of pepstatin, an inhibitor of γ- secretase activity. These studies demonstrate that γ-secretase's cleavage specificity is primarily determined by location of the γ-secretase cleavage site of APP with respect to the membrane, and that γ-secretase activity is due to the action of multiple proteases exhibiting both a pepstatin-sensitive activity and a pepstatin-insensitive activity. Given that γ-secretase is a major therapeutic target in Alzheimer's disease these studies provide important information with respect to the mechanism of Aβ production that will direct efforts to isolate the γ-secretases and potentially to develop effective therapeutic inhibitors of pathologically relevant γ-secretase activities.
UR - http://www.scopus.com/inward/record.url?scp=0033597105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033597105&partnerID=8YFLogxK
U2 - 10.1074/jbc.274.17.11914
DO - 10.1074/jbc.274.17.11914
M3 - Article
C2 - 10207012
AN - SCOPUS:0033597105
SN - 0021-9258
VL - 274
SP - 11914
EP - 11923
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 17
ER -